Z-0659-2022 Class I Terminated

Recalled by CELLTRION USA INC — Jersey City, NJ

FDA device recall Z-0659-2022 was initiated by CELLTRION USA INC on Dec 28, 2021 and is designated Class I. Reason for recall: The affected lot was placed under quarantine in September 2021 due to complaints of alleged false positives, but 243 kits were erroneously released to customers in December 2021. The recall status is terminated (terminated Jun 10, 2024). Affected quantity: 243 kits (6,075 tests).

Recall details

Product Type
Devices
Report Date
Mar 9, 2022
Initiation Date
Dec 28, 2021
Termination Date
Jun 10, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
243 kits (6,075 tests)

Product description

Celltrion DiaTrust COVID-19 Ag Rapid Test, Reference No. CT-P60 D-2 02

Reason for recall

The affected lot was placed under quarantine in September 2021 due to complaints of alleged false positives, but 243 kits were erroneously released to customers in December 2021.

Distribution pattern

US distribution to CA, FL, NJ, NY, PA, SC.

Code information

Lot COVGCCM0008

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0659-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0659-2022. Report a data issue: hello@regdatalab.com.